Science & Technology
(U33C)
990 on File
AMERICAN CHEMICAL SOCIETY
Financial strength (30%)
68/100
Reliability (20%)
55/100
Effectiveness (25%)
71/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$117K
Total Revenue
$288K
Total Expenses
$538K
Net Assets
0
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
98.6%
Fundraising Efficiency
N/A
Operating Reserve
22.43x
Liability-to-Asset
0.0%
Revenue Diversification
51.9%
Executive Compensation
$0
Compared with Peers
FY 2023
Compared with 730 similar organizations
(United States, Science & Technology, $100K–$1M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
98.6% | 84.3% |
P10P90
|
Top quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
1.4% | 13.9% |
P10P90
|
Top quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
0.0% | 0.0% |
P10P90
|
Top quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
22.4 mo | 11.3 mo |
P10P90
|
Above median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
0.0% | 0.8% |
P10P90
|
Top quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
51.9% | 93.4% |
P10P90
|
Top quarter |
|
Revenue growth
Year over year revenue growth
|
39.1% | 10.8% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
164.1% | 14.6% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
-146.0% | 2.0% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $117K | $288K | $538K | 98.6% | 0 |
| 2022 | $84K | $109K | $709K | 78.1% | 0 |
| 2021 | $148K | $13K | N/A | — | 0 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.